XML 22 R7.htm IDEA: XBRL DOCUMENT v3.22.0.1
CONSOLIDATED STATEMENTS OF EQUITY - USD ($)
shares in Thousands, $ in Thousands
Total
Cumulative Effect, Period of Adoption, Adjustment
Common Stock
Additional Paid-In Capital
Retained Earnings (Accumulated Deficit)
Retained Earnings (Accumulated Deficit)
Cumulative Effect, Period of Adoption, Adjustment
Accumulated Other Comprehensive Income (Loss)
Increase (decrease) in stockholders equity              
Adoption of new accounting standard $ 28,971 $ 500 $ 842 $ 268,327 $ (240,104) $ 500 $ (94)
Balance at beginning of the period (in shares) at Dec. 29, 2018     84,196        
Balance at beginning of the period at Dec. 29, 2018 28,971 $ 500 $ 842 268,327 (240,104) $ 500 (94)
Increase (decrease) in stockholders equity              
Stock-based compensation 52,332     52,332      
Common stock issued under employee benefit plans (in shares)     3,023        
Common stock issued under employee benefit plans 3,561   $ 30 3,531      
Common stock withheld related to net share settlement of stock-based compensation (in shares)     (445)        
Common stock withheld related to net share settlement of stock-based compensation (13,516)   $ (4) (13,512)      
Dividends (375)       (375)    
Other comprehensive income (loss) 98           98
Net income 50,434       50,434    
Balance at end of the period (in shares) at Dec. 28, 2019     86,774        
Balance at end of the period at Dec. 28, 2019 122,005   $ 868 310,678 (189,545)   4
Increase (decrease) in stockholders equity              
Adoption of new accounting standard 122,005   $ 868 310,678 (189,545)   4
Stock-based compensation 9,009     9,009      
Common stock issued under employee benefit plans (in shares)     383        
Common stock issued under employee benefit plans 3,022   $ 4 3,018      
Common stock withheld related to net share settlement of stock-based compensation (in shares)     (29)        
Common stock withheld related to net share settlement of stock-based compensation (1,028)   $ (1) (1,027)      
Other comprehensive income (loss) (391)           (391)
Net income 155,801       155,801    
Balance at end of the period (in shares) at Jan. 02, 2021     87,128        
Balance at end of the period at Jan. 02, 2021 288,418   $ 871 321,678 (33,744)   (387)
Increase (decrease) in stockholders equity              
Adoption of new accounting standard 288,418   $ 871 321,678 (33,744)   (387)
Stock-based compensation 15,474     15,474      
Common stock issued under employee benefit plans (in shares)     641        
Common stock issued under employee benefit plans 4,095   $ 6 4,089      
Common stock withheld related to net share settlement of stock-based compensation (in shares)     (42)        
Common stock withheld related to net share settlement of stock-based compensation (3,506)   $ 0 (3,506)      
Other comprehensive income (loss) 740           740
Net income 212,602       212,602    
Balance at end of the period (in shares) at Jan. 01, 2022     87,727        
Balance at end of the period at Jan. 01, 2022 517,823   $ 877 337,735 178,858   353
Increase (decrease) in stockholders equity              
Adoption of new accounting standard $ 517,823   $ 877 $ 337,735 $ 178,858   $ 353